I vaguely recall seeing something similar to this, so if its a re-run, my apologies.
Though even if so, its worth remembering some of the competitive advantages we have.
FesAbstract
Objective This study aims to compare outcomes between Novosorb Biodegradable Temporizing Matrix (BTM) and Integra collagen-chondroitin silicone for upper-extremity wound reconstruction.
Methods This retrospective study analyzed adult patients who underwent wound reconstruction with either BTM or Integra at our institution between 2015 and 2020.
Results Forty-eight patients were included: 31 (64.6%) BTM and 17 (35.4%) Integra. Mean age was 44.0 (range: 18–68) years. Age, race, sex, smoking, comorbidities, and defect size were similar between groups. Wound etiologies included 12 (25.0%) burn, 22 (45.8%) trauma, and others. Median template size was 133 cm2 for BTM and 104 cm2 for Integra (p = 0.526). Skin grafting was performed after 14 (45.2%) and 14 (82.4%) wounds treated with BTM and Integra, respectively (p = 0.028). Template complications of infection and dehiscence were comparable. Skin-graft complications occurred in five (35.7%) and three (21.4%) wounds in BTM and Integra, respectively (p = 0.031). Skin-graft failure rates were comparable (p = 0.121). Mean number of secondary procedures required after template placement was higher in the Integra group (BTM, 1.0; Integra, 1.9; p = 0.090). Final healing was achieved in 17 (54.8%) BTM and 11 (64.7%) Integra wounds (p = 0.694). Median time to healing was 4.1 months after BTM and 2.6 months after Integra placement (p = 0.014).
Conclusion Compared with Integra, BTM achieved comparable wound healing and complication rates. Fewer secondary procedures and skin grafts were observed in BTM wounds, likely as a result of the coronavirus disease 2019 pandemic. At our institution, 100 cm2 of product costs $850 for BTM and $3,150 for Integra, suggesting BTM as an economical alternative to fulfill the high functional and aesthetic requirements of upper-extremity wounds.
- Forums
- ASX - By Stock
- PNV
- PNV Media Thread
PNV Media Thread, page-2313
-
-
- There are more pages in this discussion • 956 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.38 |
Change
0.060(2.59%) |
Mkt cap ! $1.643B |
Open | High | Low | Value | Volume |
$2.35 | $2.39 | $2.33 | $2.357M | 995.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 232 | $2.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 3934 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 232 | 2.370 |
3 | 11692 | 2.360 |
5 | 20879 | 2.350 |
1 | 2161 | 2.340 |
2 | 6978 | 2.330 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 3934 | 1 |
2.390 | 185006 | 6 |
2.400 | 76851 | 7 |
2.410 | 16999 | 4 |
2.420 | 31146 | 3 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online